80.36MMarket Cap
LossP/E TTM
Key Figures
9.060Open
9.060High
1.47KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.02%Turnover Ratio
8.850Prev. Close
8.875Low
10.15KTurnover
LossP/E Static
1.05P/B
0.00%Div Yield TTM
-6.49%ROA
41.72052wk High
0.96Volume Ratio
-346.63MNet Profit
9.03MShares
-0.7445EPS TTM
1.38Beta
-9.92%ROE
2.80052wk Low
2.09%Amplitude
72.27%Gross Margin
80.36MMarket Cap
-1.89Reward/Risk
7.58%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Burning Rock Biotech Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 58 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Burning Rock Biotech Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Burning Rock Biotech Ltd Highlights
StrengthsRisks
Burning Rock Biotech Ltd News
More news coming soon, stay tuned...
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Burning Rock Biotech Ltd Info
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Ticker SymbolBNR
CompanyBurning Rock Biotech Ltd
CEOHan (Yusheng)
Websitehttps://www.brbiotech.com/
Shareholders
FAQs
What is the current price of Burning Rock Biotech Ltd (BNR)?
The current price of Burning Rock Biotech Ltd (BNR) is 8.90.
What is the symbol of Burning Rock Biotech Ltd?
The ticker symbol of Burning Rock Biotech Ltd is BNR.
What is the 52-week high of Burning Rock Biotech Ltd?
The 52-week high of Burning Rock Biotech Ltd is 41.72.
What is the 52-week low of Burning Rock Biotech Ltd?
The 52-week low of Burning Rock Biotech Ltd is 2.80.
What is the market capitalization of Burning Rock Biotech Ltd?
The market capitalization of Burning Rock Biotech Ltd is 80.36M.
What is the Earnings Per Share (EPS TTM) of Burning Rock Biotech Ltd (BNR)?
The Earnings Per Share (EPS TTM) of Burning Rock Biotech Ltd (BNR) is -0.74.
